145 related articles for article (PubMed ID: 28580639)
1. Mesenchymal Stem Cells Stabilize Axonal Transports for Autophagic Clearance of α-Synuclein in Parkinsonian Models.
Oh SH; Lee SC; Kim DY; Kim HN; Shin JY; Ye BS; Lee PH
Stem Cells; 2017 Aug; 35(8):1934-1947. PubMed ID: 28580639
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model.
Park HJ; Shin JY; Kim HN; Oh SH; Lee PH
Neurobiol Aging; 2014 Aug; 35(8):1920-8. PubMed ID: 24629674
[TBL] [Abstract][Full Text] [Related]
3. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease.
Esteves AR; Gozes I; Cardoso SM
Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997
[TBL] [Abstract][Full Text] [Related]
4. Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease.
Stykel MG; Humphries K; Kirby MP; Czaniecki C; Wang T; Ryan T; Bamm V; Ryan SD
FASEB J; 2018 Oct; 32(10):5350-5364. PubMed ID: 29688812
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cells Inhibit Transmission of α-Synuclein by Modulating Clathrin-Mediated Endocytosis in a Parkinsonian Model.
Oh SH; Kim HN; Park HJ; Shin JY; Bae EJ; Sunwoo MK; Lee SJ; Lee PH
Cell Rep; 2016 Feb; 14(4):835-849. PubMed ID: 26776513
[TBL] [Abstract][Full Text] [Related]
6. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM
Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013
[TBL] [Abstract][Full Text] [Related]
7. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
[TBL] [Abstract][Full Text] [Related]
8. The Cleavage Effect of Mesenchymal Stem Cell and Its Derived Matrix Metalloproteinase-2 on Extracellular α-Synuclein Aggregates in Parkinsonian Models.
Oh SH; Kim HN; Park HJ; Shin JY; Kim DY; Lee PH
Stem Cells Transl Med; 2017 Mar; 6(3):949-961. PubMed ID: 28297586
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells enhance α-synuclein clearance via M2 microglia polarization in experimental and human parkinsonian disorder.
Park HJ; Oh SH; Kim HN; Jung YJ; Lee PH
Acta Neuropathol; 2016 Nov; 132(5):685-701. PubMed ID: 27497943
[TBL] [Abstract][Full Text] [Related]
10. Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells.
Hu G; Gong X; Wang L; Liu M; Liu Y; Fu X; Wang W; Zhang T; Wang X
Mol Neurobiol; 2017 Apr; 54(3):2361-2372. PubMed ID: 26957304
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
Muntané G; Dalfó E; Martinez A; Ferrer I
Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
[TBL] [Abstract][Full Text] [Related]
12. Effects of α-synuclein on axonal transport.
Volpicelli-Daley LA
Neurobiol Dis; 2017 Sep; 105():321-327. PubMed ID: 27956085
[TBL] [Abstract][Full Text] [Related]
13. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J
Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237
[TBL] [Abstract][Full Text] [Related]
14. Tau protein: relevance to Parkinson's disease.
Lei P; Ayton S; Finkelstein DI; Adlard PA; Masters CL; Bush AI
Int J Biochem Cell Biol; 2010 Nov; 42(11):1775-8. PubMed ID: 20678581
[TBL] [Abstract][Full Text] [Related]
15. α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies.
Prots I; Grosch J; Brazdis RM; Simmnacher K; Veber V; Havlicek S; Hannappel C; Krach F; Krumbiegel M; Schütz O; Reis A; Wrasidlo W; Galasko DR; Groemer TW; Masliah E; Schlötzer-Schrehardt U; Xiang W; Winkler J; Winner B
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7813-7818. PubMed ID: 29991596
[TBL] [Abstract][Full Text] [Related]
16. Alterations in Activity-Dependent Neuroprotective Protein in Sporadic and Experimental Parkinson's Disease.
Chu Y; Morfini GA; Kordower JH
J Parkinsons Dis; 2016; 6(1):77-97. PubMed ID: 27003787
[TBL] [Abstract][Full Text] [Related]
17. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
18. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
[TBL] [Abstract][Full Text] [Related]
19. Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro.
Qureshi HY; Paudel HK
J Biol Chem; 2011 Feb; 286(7):5055-68. PubMed ID: 21127069
[TBL] [Abstract][Full Text] [Related]
20. Axonal transport of human alpha-synuclein slows with aging but is not affected by familial Parkinson's disease-linked mutations.
Li W; Hoffman PN; Stirling W; Price DL; Lee MK
J Neurochem; 2004 Jan; 88(2):401-10. PubMed ID: 14690528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
